Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 4:31 pm Purchase |
2025-03-31 | 13G | Mersana Therapeutics, Inc. MRSN |
Schonfeld Strategic Advisors LLC | 7,614,065 6.110% |
7,614,065 (New Position) |
Filing History |
| 2025-05-15 4:31 pm Sale |
2025-03-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Schonfeld Strategic Advisors LLC | 4,305,204 4.930% |
-929,304 (-17.75%) |
Filing History |
| 2025-05-15 4:31 pm Purchase |
2025-03-31 | 13G | Skye Bioscience, Inc. SKYE |
Schonfeld Strategic Advisors LLC | 1,617,697 5.220% |
1,617,697 (New Position) |
Filing History |
| 2025-05-15 4:30 pm Purchase |
2025-03-31 | 13G | Fate Therapeutics, Inc. FATE |
Schonfeld Strategic Advisors LLC | 7,794,513 6.800% |
7,794,513 (New Position) |
Filing History |
| 2025-05-15 4:30 pm Sale |
2025-03-31 | 13G | Applied Therapeutics, Inc. APLT |
Schonfeld Strategic Advisors LLC | 4,676,097 3.300% |
-4,093,543 (-46.68%) |
Filing History |
| 2025-02-14 4:16 pm Sale |
2024-12-31 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH |
Schonfeld Strategic Advisors LLC | 1,314,915 2.820% |
-457,800 (-25.82%) |
Filing History |
| 2025-02-14 4:15 pm Purchase |
2024-12-31 | 13G | Applied Therapeutics, Inc. APLT |
Schonfeld Strategic Advisors LLC | 8,769,640 7.540% |
8,769,640 (New Position) |
Filing History |
| 2025-02-14 4:15 pm Purchase |
2024-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Schonfeld Strategic Advisors LLC | 5,234,508 6.160% |
5,234,508 (New Position) |
Filing History |
| 2024-11-14 4:15 pm Purchase |
2024-09-30 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH |
Schonfeld Strategic Advisors LLC | 1,772,715 5.300% |
1,772,715 (New Position) |
Filing History |
| 2024-02-14 4:31 pm Sale |
2023-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Schonfeld Strategic Advisors LLC | 119 0.180% |
-3,091 (-96.30%) |
Filing History |
| 2024-02-14 4:30 pm Sale |
2023-12-31 | 13G | Grosvenor Capital Management, L.P. GCMG |
Schonfeld Strategic Advisors LLC | 41,993 0.100% |
-3,546,723 (-98.83%) |
Filing History |
| 2023-02-14 4:32 pm Sale |
2022-12-31 | 13G | MarketWise, Inc. MKTW |
Schonfeld Strategic Advisors LLC | 0 0.000% |
-1,468,900 (Position Closed) |
Filing History |
| 2023-02-14 4:31 pm Purchase |
2022-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Schonfeld Strategic Advisors LLC | 3,210 6.140% |
3,210 (New Position) |
Filing History |
| 2023-02-14 4:30 pm Sale |
2022-12-31 | 13G | Grosvenor Capital Management, L.P. GCMG |
Schonfeld Strategic Advisors LLC | 3,588,716 7.990% |
-1,121,757 (-23.81%) |
Filing History |
| 2022-06-09 4:45 pm Purchase |
2022-05-31 | 13G | Grosvenor Capital Management, L.P. GCMG |
Schonfeld Strategic Advisors LLC | 4,710,473 10.500% |
2,086,113 (+79.49%) |
Filing History |
| 2022-02-15 4:07 pm Purchase |
2021-12-31 | 13G | MarketWise, Inc. MKTW |
Schonfeld Strategic Advisors LLC | 1,468,900 5.840% |
1,468,900 (New Position) |
Filing History |
| 2022-02-14 11:36 am Purchase |
2021-12-31 | 13G | Grosvenor Capital Management, L.P. GCMG |
Schonfeld Strategic Advisors LLC | 2,624,360 6.000% |
2,624,360 (New Position) |
Filing History |
| 2022-02-14 11:35 am Purchase |
2021-12-31 | 13G | PubMatic, Inc. PUBM |
Schonfeld Strategic Advisors LLC | 517,926 1.880% |
75,726 (+17.12%) |
Filing History |
| 2022-02-14 11:34 am Purchase |
2021-12-31 | 13G | Churchill Capital Corp V CCV |
Schonfeld Strategic Advisors LLC | 16,518 3.300% |
16,518 (New Position) |
Filing History |
| 2021-02-16 1:29 pm Purchase |
2020-12-31 | 13G | PubMatic, Inc. PUBM |
Schonfeld Strategic Advisors LLC | 442,200 7.490% |
442,200 (New Position) |
Filing History |